Lonquek for Autologous Stem Cell Mobilization

Inclusion Criteria: * Patients with confirmed multiple myeloma or Hodgkins or non Hodgkin lymphoma at need of autologous stem cell transplantation. * Disease must be chemosensitive or stable status to prior therapy before transplant. * Age between 18 and 65 years inclusive. * ECOG performance status 0, 1 or 2. * Written informed consent. * Adequate birth control in fertile patients. Exclusion Criteria: * Lymphoma patients that did not fulfill the inclusion criteria. * Patients with factors predicting poor mobilization including \>3 lines of previous chemotherapy, extensive irradiation, patients that received stem cell toxicity drugs like Melphalan, Fludarabine, \>2 courses of Revlimid, age \>65 years, platelets counts \<100x109/L, WBC\<2.5x109/L or WBC \> 35x109/L. * Previous autologous stem cell transplantation. * Inability to tolerate peripheral blood stem cell harvest. * Peripheral venous access not possible.